Effentora

Effentora is a buccal film containing fentanyl citrate, used for managing breakthrough pain in adults already on opioid therapy. This fast-acting medication is designed for oral mucosal application.

Effentora is primarily used for the management of breakthrough pain in adults who are already receiving opioid therapy for chronic cancer pain. It is designed to provide rapid relief when pain flares up between scheduled doses of other pain medications. The buccal film adheres to the inner cheek, allowing the active ingredient, fentanyl citrate, to be absorbed through the oral mucosa.

Effentora may cause common side effects such as nausea, dizziness, and headache. Some users might experience drowsiness or constipation. These effects can vary from person to person and may subside as the body adjusts to the medication.

Effentora should be handled with care, especially by those with a history of respiratory issues or substance abuse. It is important to follow the prescribed usage instructions to minimize the risk of side effects. The medication should be stored safely to prevent accidental exposure, particularly to children and pets.

Effentora may interact with other medications, including those that affect the central nervous system, such as sedatives and alcohol. It is important to consult with a healthcare provider before combining Effentora with other medications to avoid potential adverse effects.